F/M Investments »

Cytokinetics shares owned by F/M Investments

Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by F/M Investments from 13F filings

Historical chart of F/M Investments investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by F/M Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by F/M Investments

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.0M 30k 65.91

More positions owned by F/M Investments

Dimensional Etf Trust Core Fixed Incom (DFCF)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Apple (AAPL)
Vanguard Intl Equity Index F Allwrld Ex Us (VEU)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
RBB Us Treas 3 Mnth (TBIL)
Amazon (AMZN)
RBB Fm Opportunistic (ZHOG)
Meta Platforms Cl A (META)
RBB F/m 3 Year Inves (ZTRE)
Mastercard Incorporated Cl A (MA)
Eli Lilly & Co. (LLY)
Palo Alto Networks (PANW)

View all positions for F/M Investments

Top funds holding Cytokinetics

T. Rowe Price Investment Management
BlackRock
FMR
Vanguard Group
Wellington Management Company
Vanguard Portfolio Management
State Street Corporation
Vanguard Capital Management
Geode Capital Management
Bank of America Corporation
Susquehanna International
Rtw Investments
Armistice Capital
Goldman Sachs Group
Polar Capital Holdings

View all funds holding Cytokinetics